{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T03:14:15Z","timestamp":1783566855144,"version":"3.55.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Funct Integr Genomics"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s10142-026-01972-3","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T02:37:00Z","timestamp":1783564620000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["EBV-informed multi-omics target prioritization and structure-based drug repurposing reveal potential therapeutic strategies for multiple sclerosis"],"prefix":"10.1007","volume":"26","author":[{"given":"Nevil M.","family":"Lal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harshit","family":"Sajal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aswin","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asna","family":"R.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadiya","family":"Fathima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Raju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5231-6678","authenticated-orcid":false,"given":"Anuroopa G.","family":"Nadh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,9]]},"reference":[{"key":"1972_CR1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","volume":"1\u20132","author":"MJ Abraham","year":"2015","unstructured":"Abraham MJ, Murtola T, Schulz R et al (2015) GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 1\u20132:19\u201325. https:\/\/doi.org\/10.1016\/j.softx.2015.06.001","journal-title":"SoftwareX"},{"key":"1972_CR2","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1523\/JNEUROSCI.2864-16.2017","volume":"38","author":"JT Ahrendsen","year":"2018","unstructured":"Ahrendsen JT, Harlow DE, Finseth LT et al (2018) The Protein Tyrosine Phosphatase Shp2 Regulates Oligodendrocyte Differentiation and Early Myelination and Contributes to Timely Remyelination. J Neurosci 38:787\u2013802. https:\/\/doi.org\/10.1523\/JNEUROSCI.2864-16.2017","journal-title":"J Neurosci"},{"key":"1972_CR3","doi-asserted-by":"publisher","first-page":"514","DOI":"10.3934\/Neuroscience.2025026","volume":"12","author":"ASPM Arachchige","year":"2025","unstructured":"Arachchige ASPM, El Choueiri J, Pellican\u00f2 F et al (2025) A review of multiple sclerosis: from pathophysiology to latest therapeutic advances. AIMS Neurosci 12:514\u2013538. https:\/\/doi.org\/10.3934\/Neuroscience.2025026","journal-title":"AIMS Neurosci"},{"key":"1972_CR4","doi-asserted-by":"crossref","unstructured":"Aronson JK (2016) Gusperimus. Meyler\u2019s Side Effects of Drugs. Elsevier, p 635","DOI":"10.1016\/B978-0-444-53717-1.00829-5"},{"key":"1972_CR5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.286.24.3083","volume":"286","author":"A Ascherio","year":"2001","unstructured":"Ascherio A, Munger KL, Lennette ET et al (2001) Epstein-Barr virus antibodies and risk of multiple sclerosis. JAMA 286:3083. https:\/\/doi.org\/10.1001\/jama.286.24.3083","journal-title":"JAMA"},{"key":"1972_CR6","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.3390\/brainsci15101097","volume":"15","author":"E Barbuti","year":"2025","unstructured":"Barbuti E, Piervincenzi C, Ruggieri S, Petracca M (2025) Sex-Related Differences in Lifestyle Factors Affecting Multiple Sclerosis Susceptibility and Disease Progression. Brain Sci 15:1097. https:\/\/doi.org\/10.3390\/brainsci15101097","journal-title":"Brain Sci"},{"key":"1972_CR7","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.neurol.2026.04.002","volume":"182","author":"G Bellucci","year":"2026","unstructured":"Bellucci G, Mechelli R, Bigi R et al (2026) The role of Epstein-Barr virus in multiple sclerosis: From pathogenesis to therapeutic potential. Rev Neurol (Paris) 182:467\u2013472. https:\/\/doi.org\/10.1016\/j.neurol.2026.04.002","journal-title":"Rev Neurol (Paris)"},{"key":"1972_CR8","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1126\/science.abj8222","volume":"375","author":"K Bjornevik","year":"2022","unstructured":"Bjornevik K, Cortese M, Healy BC et al (2022) Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis. Sci (1979) 375:296\u2013301. https:\/\/doi.org\/10.1126\/science.abj8222","journal-title":"Sci (1979)"},{"key":"1972_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-023-00775-5","author":"K Bjornevik","year":"2023","unstructured":"Bjornevik K, M\u00fcnz C, Cohen JI, Ascherio A (2023) Epstein\u2013Barr virus as a leading cause of multiple sclerosis: mechanisms and implications. Nat Rev Neurol. https:\/\/doi.org\/10.1038\/s41582-023-00775-5","journal-title":"Nat Rev Neurol"},{"key":"1972_CR10","doi-asserted-by":"publisher","first-page":"D520","DOI":"10.1093\/nar\/gky949","volume":"47","author":"SK Burley","year":"2019","unstructured":"Burley SK, Berman HM, Bhikadiya C et al (2019) Protein Data Bank: the single global archive for 3D macromolecular structure data. Nucleic Acids Res 47:D520\u2013D528. https:\/\/doi.org\/10.1093\/nar\/gky949","journal-title":"Nucleic Acids Res"},{"key":"1972_CR11","doi-asserted-by":"publisher","first-page":"D998","DOI":"10.1093\/nar\/gkae1070","volume":"53","author":"M Cerezo","year":"2025","unstructured":"Cerezo M, Sollis E, Ji Y et al (2025) The NHGRI-EBI GWAS catalog: standards for reusability, sustainability and diversity. Nucleic Acids Res 53:D998\u2013D1005. https:\/\/doi.org\/10.1093\/nar\/gkae1070","journal-title":"Nucleic Acids Res"},{"key":"1972_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/1752-0509-8-S4-S11","volume":"8","author":"C-H Chin","year":"2014","unstructured":"Chin C-H, Chen S-H, Wu H-H et al (2014) Cytohubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol 8:S11. https:\/\/doi.org\/10.1186\/1752-0509-8-S4-S11","journal-title":"BMC Syst Biol"},{"key":"1972_CR13","doi-asserted-by":"publisher","first-page":"D138","DOI":"10.1093\/nar\/gkad965","volume":"52","author":"E Clough","year":"2024","unstructured":"Clough E, Barrett T, Wilhite SE et al (2024) NCBI GEO: archive for gene expression and epigenomics data sets: 23-year update. Nucleic Acids Res 52:D138\u2013D144. https:\/\/doi.org\/10.1093\/nar\/gkad965","journal-title":"Nucleic Acids Res"},{"key":"1972_CR14","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1001\/archneur.63.6.noc50328","volume":"63","author":"GN DeLorenze","year":"2006","unstructured":"DeLorenze GN, Munger KL, Lennette ET et al (2006) Epstein-Barr Virus and Multiple Sclerosis. Arch Neurol 63:839. https:\/\/doi.org\/10.1001\/archneur.63.6.noc50328","journal-title":"Arch Neurol"},{"key":"1972_CR15","doi-asserted-by":"publisher","first-page":"6177","DOI":"10.1021\/jm051256o","volume":"49","author":"RA Friesner","year":"2006","unstructured":"Friesner RA, Murphy RB, Repasky MP et al (2006) Extra Precision Glide: Docking and Scoring Incorporating a Model of Hydrophobic Enclosure for Protein\u2013Ligand Complexes. J Med Chem 49:6177\u20136196. https:\/\/doi.org\/10.1021\/jm051256o","journal-title":"J Med Chem"},{"key":"1972_CR16","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ncl.2020.09.002","volume":"39","author":"C Goldschmidt","year":"2021","unstructured":"Goldschmidt C, McGinley MP (2021) Advances in the Treatment of Multiple Sclerosis. Neurol Clin 39:21\u201333. https:\/\/doi.org\/10.1016\/j.ncl.2020.09.002","journal-title":"Neurol Clin"},{"key":"1972_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/ene.12798","volume":"22","author":"N Grigoriadis","year":"2015","unstructured":"Grigoriadis N, van Pesch V (2015) A basic overview of multiple sclerosis immunopathology. Eur J Neurol 22:3\u201313. https:\/\/doi.org\/10.1111\/ene.12798","journal-title":"Eur J Neurol"},{"key":"1972_CR18","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000037297","volume":"103","author":"M Haki","year":"2024","unstructured":"Haki M, AL-Biati HA, Al-Tameemi ZS et al (2024) Review of multiple sclerosis: epidemiology, etiology, pathophysiology, and treatment. Medicine 103:e37297. https:\/\/doi.org\/10.1097\/MD.0000000000037297","journal-title":"Medicine"},{"key":"1972_CR19","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1186\/s40001-026-04317-9","volume":"31","author":"Y Jia","year":"2026","unstructured":"Jia Y, Ren Y, Yu Y et al (2026) SHP2 in microglia attenuates neuroinflammation and cognitive deficits in vascular dementia by modulating the FAK\/Src\/PU. 1\/IRF8 pathway. Eur J Med Res 31:691. https:\/\/doi.org\/10.1186\/s40001-026-04317-9","journal-title":"Eur J Med Res"},{"key":"1972_CR20","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2425537122","author":"Y Jiang","year":"2025","unstructured":"Jiang Y, Liu Q, Stridh P et al (2025) Multiomics integration prioritizes potential drug targets for multiple sclerosis. Proc Natl Acad Sci U S A. https:\/\/doi.org\/10.1073\/pnas.2425537122","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1972_CR21","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s44197-025-00353-6","volume":"15","author":"G Khan","year":"2025","unstructured":"Khan G, Hashim MJ (2025) Epidemiology of Multiple Sclerosis: Global, Regional, National and Sub-National-Level Estimates and Future Projections. J Epidemiol Glob Health 15:21. https:\/\/doi.org\/10.1007\/s44197-025-00353-6","journal-title":"J Epidemiol Glob Health"},{"key":"1972_CR22","doi-asserted-by":"publisher","first-page":"W90","DOI":"10.1093\/nar\/gkw377","volume":"44","author":"MV Kuleshov","year":"2016","unstructured":"Kuleshov MV, Jones MR, Rouillard AD et al (2016) Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res 44:W90\u2013W97. https:\/\/doi.org\/10.1093\/nar\/gkw377","journal-title":"Nucleic Acids Res"},{"key":"1972_CR23","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1750-3639.2007.00064.x","volume":"17","author":"H Lassmann","year":"2007","unstructured":"Lassmann H, Br\u00fcck W, Lucchinetti CF (2007) The Immunopathology of Multiple Sclerosis: An Overview. Brain Pathol 17:210\u2013218. https:\/\/doi.org\/10.1111\/j.1750-3639.2007.00064.x","journal-title":"Brain Pathol"},{"key":"1972_CR24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.neurol.2015.10.006","volume":"172","author":"E Leray","year":"2016","unstructured":"Leray E, Moreau T, Fromont A, Edan G (2016) Epidemiology of multiple sclerosis. Rev Neurol (Paris) 172:3\u201313. https:\/\/doi.org\/10.1016\/j.neurol.2015.10.006","journal-title":"Rev Neurol (Paris)"},{"key":"1972_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2024.112505","volume":"194","author":"Y Liu","year":"2024","unstructured":"Liu Y, Wang Q, Zhao Y et al (2024) Identification of novel drug targets for multiple sclerosis by integrating plasma genetics and proteomes. Exp Gerontol 194:112505. https:\/\/doi.org\/10.1016\/j.exger.2024.112505","journal-title":"Exp Gerontol"},{"key":"1972_CR26","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S (2014) Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 15:550. https:\/\/doi.org\/10.1186\/s13059-014-0550-8","journal-title":"Genome Biol"},{"key":"1972_CR27","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","volume":"27","author":"G Madhavi Sastry","year":"2013","unstructured":"Madhavi Sastry G, Adzhigirey M, Day T et al (2013) Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. J Comput Aided Mol Des 27:221\u2013234. https:\/\/doi.org\/10.1007\/s10822-013-9644-8","journal-title":"J Comput Aided Mol Des"},{"key":"1972_CR28","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/s12031-025-02446-0","volume":"75","author":"TA Majrashi","year":"2025","unstructured":"Majrashi TA, Alsayari A, Alshahrani MY et al (2025) Irilone and Lupinisoflavone C as Potential Plant-Based Modulators of S1PR1 for Neuroimmune Modulation in Multiple Sclerosis: Insights from Molecular Docking and Dynamics. J Mol Neurosci 75:156. https:\/\/doi.org\/10.1007\/s12031-025-02446-0","journal-title":"J Mol Neurosci"},{"issue":"20","key":"1972_CR29","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1001\/jama.2022.14236","volume":"328","author":"R Marcus","year":"2022","unstructured":"Marcus R (2022) What is multiple sclerosis? JAMA 328:2078. https:\/\/doi.org\/10.1001\/jama.2022.14236","journal-title":"JAMA"},{"key":"1972_CR30","doi-asserted-by":"publisher","unstructured":"Niogret C, Birchmeier W, Guarda G (2019) SHP-2 in lymphocytes\u2019 cytokine and inhibitory receptor signaling. Front Immunol 10. https:\/\/doi.org\/10.3389\/fimmu.2019.02468","DOI":"10.3389\/fimmu.2019.02468"},{"key":"1972_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-024-03222-1","volume":"15","author":"J Pang","year":"2025","unstructured":"Pang J, Cen C, Tian Y et al (2025) Targeting Shp2 as a therapeutic strategy for neurodegenerative diseases. Transl Psychiatry 15:6. https:\/\/doi.org\/10.1038\/s41398-024-03222-1","journal-title":"Transl Psychiatry"},{"key":"1972_CR32","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1093\/rheumatology\/ket451","volume":"53","author":"M Perenyei","year":"2014","unstructured":"Perenyei M, Jayne DRW, Flossmann O (2014) Gusperimus: immunological mechanism and clinical applications. Rheumatology 53:1732\u20131741. https:\/\/doi.org\/10.1093\/rheumatology\/ket451","journal-title":"Rheumatology"},{"key":"1972_CR33","doi-asserted-by":"publisher","first-page":"204","DOI":"10.55453\/rjmm.2026.129.2.9","volume":"129","author":"A Ple\u0219a","year":"2026","unstructured":"Ple\u0219a A, S\u00eerbu C-A, Vasiliu O et al (2026) The Evolving Landscape of Multiple Sclerosis Therapy. Romanian J Military Med 129:204\u2013211. https:\/\/doi.org\/10.55453\/rjmm.2026.129.2.9","journal-title":"Romanian J Military Med"},{"key":"1972_CR34","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.neuroscience.2024.12.029","volume":"567","author":"S Rida Zainab","year":"2025","unstructured":"Rida Zainab S, Zeb Khan J, Khalid Tipu M et al (2025) A review on multiple sclerosis: Unravelling the complexities of pathogenesis, progression, mechanisms and therapeutic innovations. Neuroscience 567:133\u2013149. https:\/\/doi.org\/10.1016\/j.neuroscience.2024.12.029","journal-title":"Neuroscience"},{"key":"1972_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-026-37613-9","volume":"16","author":"H Sajal","year":"2026","unstructured":"Sajal H, Mohan A, Ravi V et al (2026) Computational identification of multi-target natural compounds from Sesbania grandiflora as potential therapeutic agents against Klebsiella pneumoniae. Sci Rep 16:7782. https:\/\/doi.org\/10.1038\/s41598-026-37613-9","journal-title":"Sci Rep"},{"key":"1972_CR36","doi-asserted-by":"publisher","first-page":"962","DOI":"10.3390\/biomedicines14050962","volume":"14","author":"LMS Schleicher","year":"2026","unstructured":"Schleicher LMS, Zivalj D, Diamee HJF et al (2026) Epstein\u2013Barr Virus and Multiple Sclerosis: A Narrative Review on Prevention and the Concept of an Infection-Driven Disease. Biomedicines 14:962. https:\/\/doi.org\/10.3390\/biomedicines14050962","journal-title":"Biomedicines"},{"key":"1972_CR37","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1084\/jem.20071030","volume":"204","author":"B Serafini","year":"2007","unstructured":"Serafini B, Rosicarelli B, Franciotta D et al (2007) Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain. J Exp Med 204:2899\u20132912. https:\/\/doi.org\/10.1084\/jem.20071030","journal-title":"J Exp Med"},{"key":"1972_CR38","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O et al (2003) Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction Networks. Genome Res 13:2498\u20132504. https:\/\/doi.org\/10.1101\/gr.1239303","journal-title":"Genome Res"},{"key":"1972_CR39","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1002\/ana.78043","volume":"99","author":"S Simpson-Yap","year":"2026","unstructured":"Simpson-Yap S, Morwitch E, Tanner SA et al (2026) Epstein\u2013Barr virus, lower vitamin D, low sun exposure, and <scp>HLA<\/scp> \u2010 <scp>DRB1<\/scp> *1501 risk variant share common epigenetic pathways leading to multiple sclerosis onset. Ann Neurol 99:341\u2013355. https:\/\/doi.org\/10.1002\/ana.78043","journal-title":"Ann Neurol"},{"key":"1972_CR40","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41579-022-00770-5","volume":"21","author":"SS Soldan","year":"2023","unstructured":"Soldan SS, Lieberman PM (2023) Epstein\u2013Barr virus and multiple sclerosis. Nat Rev Microbiol 21:51\u201364. https:\/\/doi.org\/10.1038\/s41579-022-00770-5","journal-title":"Nat Rev Microbiol"},{"key":"1972_CR41","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk D, Kirsch R, Koutrouli M et al (2023) The STRING database in 2023: protein\u2013protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res 51:D638\u2013D646. https:\/\/doi.org\/10.1093\/nar\/gkac1000","journal-title":"Nucleic Acids Res"},{"key":"1972_CR42","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012186.pub2","author":"I Tramacere","year":"2023","unstructured":"Tramacere I, Virgili G, Perduca V et al (2023) Adverse effects of immunotherapies for multiple sclerosis: a network meta-analysis. Cochrane Database Syst Reviews 2023. https:\/\/doi.org\/10.1002\/14651858.CD012186.pub2","journal-title":"Cochrane Database Syst Reviews 2023"},{"key":"1972_CR43","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1002\/ddr.22100","volume":"84","author":"N Wang","year":"2023","unstructured":"Wang N, Zhu S, Lv D et al (2023) Allosteric modulation of SHP2: Quest from known to unknown. Drug Dev Res 84:1395\u20131410. https:\/\/doi.org\/10.1002\/ddr.22100","journal-title":"Drug Dev Res"},{"key":"1972_CR44","doi-asserted-by":"publisher","unstructured":"Wei W, Ma D, Li L, Zhang L (2021) Progress in the application of drugs for the treatment of multiple sclerosis. Front Pharmacol 12. https:\/\/doi.org\/10.3389\/fphar.2021.724718","DOI":"10.3389\/fphar.2021.724718"},{"key":"1972_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.824926","author":"JH Yang","year":"2022","unstructured":"Yang JH, Rempe T, Whitmire N et al (2022) Therapeutic advances in multiple sclerosis. Front Neurol. https:\/\/doi.org\/10.3389\/fneur.2022.824926","journal-title":"Front Neurol"}],"container-title":["Functional &amp; Integrative Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10142-026-01972-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10142-026-01972-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10142-026-01972-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T02:37:03Z","timestamp":1783564623000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10142-026-01972-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,9]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["1972"],"URL":"https:\/\/doi.org\/10.1007\/s10142-026-01972-3","relation":{},"ISSN":["1438-793X","1438-7948"],"issn-type":[{"value":"1438-793X","type":"print"},{"value":"1438-7948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,9]]},"assertion":[{"value":"20 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"183"}}